Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Vinorelbine × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 9 Neoplasm Metastasis 6 Hodgkin Disease 6 Neoplasms 4 Recurrence 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2 Mesothelioma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Carcinoma 2 Breast Neoplasms, Male 2 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Pleural Effusion, Malignant 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Non - Small Cell Lung Cancer NSCLC 1 Neuroendocrine Tumors 1 Neuralgia 1 Metatropic dwarfism 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Locally Advanced Non-Small Cell Lung Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Desmoplastic Small Round Cell Tumor 1

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡